Dr. Reddy’s dermatologicals
The Indian drugmaker plans to launch three branded dermatological products in the U.S. by the end of 2009 through its newly-established Bridgewater, N.J.-based Promius Pharma subsidiary. The products, which were in-licensed and co-developed, include: EpiCeram skin barrier emulsion for atopic dermatitis, Scytera foam for psoriasis and Promiseb cream for seborrheic dermatitis. Other topical products are in development. Dr. Reddy's established Promius as a platform for its U.S. branded specialty drug business (1PharmAsia News, Aug. 19, 2008)
You may also be interested in...
MUMBAI - In what could be a significant push to its dermatology business in the U.S., Dr Reddy's Labs has carved out a new company - Promius Pharma to establish a distinct identity for its branded specialty products
In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into the impact on biopharma commercial activities.
TytoCare has raised $50m in funding, which will be used to expand the reach of its telehealth solutions.